


Searching News Database: Ther-Rx
HSMN NewsFeed - 20 Jul 2026
Mentari Therapeutics Appoints Industry Veteran Greg Divis as Chief Executive Officer
Mentari Therapeutics Appoints Industry Veteran Greg Divis as Chief Executive Officer
HSMN NewsFeed - 7 Jul 2010
K-V Pharmaceutical Company Announces the Election of New Independent Member to Board of Directors
K-V Pharmaceutical Company Announces the Election of New Independent Member to Board of Directors
HSMN NewsFeed - 11 Jun 2010
KV Pharmaceutical Company Announces New Board Members and Restructuring of Senior Executive Management
KV Pharmaceutical Company Announces New Board Members and Restructuring of Senior Executive Management
HSMN NewsFeed - 11 Dec 2008
Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance
Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance
HSMN NewsFeed - 15 May 2008
KV Pharmaceutical Company Announces Approval for the 50 mg Strength of Generic Version of Toprol-XL(R)
KV Pharmaceutical Company Announces Approval for the 50 mg Strength of Generic Version of Toprol-XL(R)
HSMN NewsFeed - 18 Feb 2008
Paladin Labs & KV Pharmaceuticals Sign Distribution For Micro-K(R) Extencaps(R) Capsules
Paladin Labs & KV Pharmaceuticals Sign Distribution For Micro-K(R) Extencaps(R) Capsules
HSMN NewsFeed - 25 Oct 2007
KV Pharmaceutical Announces FDA Approval for Morphine ER 100 mg and 200 mg Tablets
KV Pharmaceutical Announces FDA Approval for Morphine ER 100 mg and 200 mg Tablets
HSMN NewsFeed - 30 Jul 2007
KV Pharmaceutical Announces U.S. Food and Drug Administration Approval of EvaMist(TM)
KV Pharmaceutical Announces U.S. Food and Drug Administration Approval of EvaMist(TM)
HSMN NewsFeed - 18 May 2007
KV Pharmaceutical Company Announces Approval for Two Strengths of Generic Versions of Toprol-XL(R)
KV Pharmaceutical Company Announces Approval for Two Strengths of Generic Versions of Toprol-XL(R)
HSMN NewsFeed - 16 May 2007
KV Pharmaceutical Company Completes Acquisition of U.S. Rights to EvaMist(TM)
KV Pharmaceutical Company Completes Acquisition of U.S. Rights to EvaMist(TM)
HSMN NewsFeed - 6 Mar 2007
Jury Finds in Favor of ETHEX/KV on All Claims Against KV Pharmaceutical and ETHEX Subsidiary
Jury Finds in Favor of ETHEX/KV on All Claims Against KV Pharmaceutical and ETHEX Subsidiary
Additional items found! 24
Members Archive contains
24 additional stories matching:
Ther-Rx
(Password required)
Ther-Rx
(Password required)
